StandoutStocks.com: "Stocks that Standout" picks for today are: ITUI, LYRI, PSSR, SKYT, VION

Dec 08, 2008 (M2 PRESSWIRE via COMTEX) -- VION | Quote | Chart | News | PowerRating -- Dec 8, 2008 StandoutStocks.com "Stocks that Standout" picks for today are: i2Telecom International, Inc. (OTCBB: ITUI), Lyris, Inc. (OTCBB: LYRI), PASSUR Aerospace, Inc. (OTCBB: PSSR), SkyTerra Communications (OTCBB: SKYT), VION PHARMACEUTICALS, INC. (OTCBB: VION)...and Proudly Introducing Proprietary Push Technology (PPT).

The Newest and Revolutionary Technology for Increasing Investor Visability.

REAL Awareness for REAL Companies.

Click below for a full demonstration.

http://newmediaadvisors.info/newmedia.swf

Sign-up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at www.Standoutstocks.com

Dec 08, 2008 -- i2Telecom International, Inc. ("i2Telecom(R)") (OTCBB: ITUI), a leading developer of award-winning patented and innovative high-quality mobile applications and services, today announced that its leading Voice over Internet Protocol ("VoIP") solution, MyGlobalTalk(TM), was included in a special report highlighting the advantages of VoIP that was distributed in USA Today, the largest circulation daily newspaper in the nation, on Friday, December 5, 2008.

The extensive review of the overall benefits of VoIP, including the specific benefits of VoIP for long distance and mobile calling purposes, was included in issues of the paper distributed in five major metropolitan cities, including New York, Los Angeles, Atlanta, Baltimore/Washington and Chicago. The insert was available in over 750,000 papers, which have a pass-along readership of approximately 1.8 million readers, and was designed to provide business-oriented readers with a broader understanding of VoIP and the current and future applications for the technology.

i2Telecom's Chief Executive Officer, Paul Arena, was interviewed for a feature in the report entitled "Taking VoIP Mobile", which included a description of i2Telecom's MyGlobalTalk(TM), a leading, low-cost international calling solution for cell and land phones that is very user-friendly and does not have to be tethered to a computer. i2Telecom also advertised 20 minutes of free calling time with MyGlobalTalk(TM) on the cover of the special insert.

"We were very pleased that USA Today recognized the timeliness of explaining the phenomenal value of VoIP in a challenging economic environment, and we were thrilled that MyGlobalTalk(TM) was featured as one of the leading mobile VoIP solutions," observed Mr. Arena.

About i2Telecom International, Inc.

i2Telecom International, Inc. is a leading developer of award-winning patented and innovative high-quality mobile applications products and services that employ best-of-breed VoIP technology and use a combination of the Company's own services network and the Internet to deliver high-quality phone calls, streaming video and text chat to customers on a global scale. i2Telecom International provides its VoiceStick(R), MyGlobalTalk(TM), Digital Portal communications and microgateway adapters for VoIP long-distance and other enhanced communication services to its subscribers. Its patent pending services technology platform is compliant with the Session Initiation Protocol ("SIP") telecommunications industry standard.

Dec 08, 2008 -- Lyris, Inc. (OTCBB: LYRI), the online marketing expert, today announced Lyris HQ Mobile, a new SMS texting solution that allows marketers to send timely, relevant and targeted text communications to opt-in audiences. With the introduction of Lyris HQ Mobile into the Lyris HQ integrated online marketing suite, today's marketers can now streamline online and mobile marketing campaigns within the same rich interface, reducing the cost and complexity of managing campaigns, while increasing ROI.

Marketing channels continue to expand and marketers need to take full advantage of consumers' busy and active lifestyles. According to the Mobile Marketing Association's Annual Mobile Attitude and Usage Study, one in four mobile subscribers in the U.S. and Western Europe expressed either strong or moderate interest in mobile marketing efforts.(1) JupiterResearch, a Forrester Research company, predicts that by 2013, there will be 371 million U.S. wireless subscribers, and of those, 201 million will be SMS users.(2)

"Mobile device users are continuing to grow in number which presents significant opportunities for marketers that want to strengthen relationships with their core audiences," said Blaine Mathieu, chief marketing officer, Lyris, Inc. "Lyris HQ Mobile allows marketers to broaden engagement with prospects and customers, wherever they spend their time."

In a recent Forrester Research report, David Daniels, vice president and principal analyst confirmed this by writing, "Marketers must consider the impact of emerging communication channels and of increasing favorability of text messages on specific demographic segments." (3)

Enabling Marketers to Engage Consumers Anytime, Anywhere

With today's mobile consumer, online marketers have the added pressure of supporting and tracking campaigns with both online and mobile elements. Lyris HQ Mobile allows users to sign up for SMS messages via text message or by completing an opt-in form. Lyris HQ Mobile handles all opt-in requirements set forth by the mobile carriers and provides reports back to marketers in real-time so they are aware of what is working and what needs improvement.

There are many use cases for Lyris HQ Mobile. These include community organizations providing timely updates to their members, promoters who send SMS texts to concert-goers who have opted in to receive messages while attending a show, or tradeshow sponsors who want to drive traffic to a specific location or event within a conference.

Capabilities and features of Lyris HQ Mobile include:

-- The ability to send one-time messages immediately, as well as on a scheduled or recurring basis to specific users

-- The capability to target messages to individuals or groups of subscribers that provide users with exclusive offers, polls or location/event specific coupons

-- Support for a broad range of campaign types including surveys, contests, transactional messages, and promotional copy

-- Dedicated, customizable shortcode or shared shortcode options are available

-- Query and reporting capabilities that provide marketers with insight such as the status of a message, individual response rates and return of messages sent to bad numbers

-- Enforced double opt-in process as required by wireless carriers

-- API-based interface allows easy connection to other applications

"Today's marketers are forced to expand their marketing channels into media like mobile while also increasing their level of reporting and analysis," said Jim Sterne, chairman of the Web Analytics Association. "Solutions that can integrate these functions and tie results into an overall digital marketing campaign will be a key asset to marketers looking for competitive advantage in today's economy."

Availability

Lyris HQ Mobile is available as an API-based solution. Lyris has partnered with Air2Web to help provide SMS to Lyris HQ customers.

About Lyris, Inc.

Lyris, Inc. is the online marketing expert delivering the right mix of software technology and industry knowledge to help its customers simplify their marketing efforts and optimize campaign ROI. Through the delivery of the industry's first on-demand integrated marketing suite, Lyris HQ, and knowledge-sharing community, www.lyrishq.com, to secure and reliable on-premise solutions, including Lyris ListManager, Lyris provides customers the right tools to optimize the management, collaboration and execution of their online and mobile marketing initiatives. These sophisticated, yet easy-to-use tools provide marketers a suite of best-of-breed applications for managing email marketing campaigns, publishing and managing Web site content, creating landing pages, optimizing Web sites and managing pay per click campaigns. Clients include Nokia, Adobe, PalmSource, Johns Hopkins University and JupiterMedia.

About Air2Web, Inc.

Launched in 1999, Air2Web helps marketers harness the power of mobile to engage with their consumers. Over the past 10 years, Air2Web has launched thousands of mobile marketing campaigns. Air2Web offers companies the tools and technology to promote products and brands, improve the efficiency of customer service and enable mobile transactions, anytime, anywhere. Air2Web is the trusted mobile resource for some of the largest, most influential brands in the world, including AT&T, Procter & Gamble, WalMart, Starbucks, UPS and many more.

Dec 08, 2008 -- PASSUR Aerospace, Inc. (OTCBB: PSSR | Quote | Chart | News | PowerRating) announced today that City of Sugar Land has contracted for PASSUR FBO for Sugar Land Regional Airport -- a unique software suite designed to ensure FBOs are never surprised by an arrival, market effectively to maximize fuel volume, and achieve the most profitable sales while providing their customers the right price.

"As one of the premier FBOs in the country (as noted in AIN's most recent survey), we take great pride in the service we provide to our customers," said Phillip Savko, Director of Sugar Land Regional Airport. "We look forward to taking advantage of all PASSUR has to offer."

"Sugar Land Regional FBO has a reputation for excellence -- we're pleased they have integrated PASSUR FBO into their best practices," said Jim Barry, president and CEO of PASSUR Aerospace.

PASSUR FBO provides real-time flight, customer, and airspace status for customer service, line operations, and marketing through visual flight tracking and web dashboards. The program includes detailed marketing reports and analytics for FBO managers and marketing staff. It is based on the PASSUR proprietary database powered by the PASSUR radar network deployed throughout the U.S. and abroad.

About PASSUR Aerospace, Inc.

PASSUR Aerospace is changing the way aviation and aerospace information is collected, analyzed, and delivered. PASSUR Aerospace owns and operates a unique database of flight information with proprietary decision-making software, primarily powered by a growing international network of passive radars (PASSURs) located at more than 85 airports world-wide, including 34 of the top 35 U.S. airports -- from which it provides PASSUR information, analytics, and decision support tools to improve the financial condition and operational efficiency of organizations. PASSUR Aerospace offers unique user-friendly information, as well as decision support algorithms, which provide innovative commercial air traffic solutions to more than 50 airports, including 8 of the top 10 U.S. airports; to dozens of airlines, including 7 of the top 10 U.S. airlines; and to more than 180 corporate aviation customers, as well as to the U.S. Government. In addition, the company has created and implemented collaborative web-based software that allows the company's customers to instantly share information to improve individual and joint decision-making, creating additional value for those customers.

Dec 08, 2008 -- Mobile Satellite Ventures (MSV) today announced it has changed its name to SkyTerra Communications (OTCBB: SKYT). SkyTerra, presently the name of MSV's parent company (SkyTerra Communications Inc.), has become the name for all MSV-named entities operating in the United States and Canada.

"Over the course of the past several years we have worked diligently to simplify MSV's ownership structure, resulting in SkyTerra Communications now owning 99.3% of the company," said Alexander H. Good, chairman, CEO and president of SkyTerra. "We are very pleased with this accomplishment and with our singular company name that reflects this simplification."

MSV's Canadian Joint Venture Partner Mobile Satellite Ventures (Canada) Inc. is also changing its name to SkyTerra (Canada) Inc. to coincide with this change. Since the partners provide mobile satellite services on a seamless, North American-wide basis, this will facilitate a harmonized approach to the provisioning and branding of services on both sides of the border.

About SkyTerra Communications

SkyTerra Communications delivers mobile wireless voice and data services primarily for public safety, security, fleet management and asset tracking in the U.S. and Canada. The company's next-generation integrated satellite-terrestrial communications network is expected to provide seamless, transparent and ubiquitous wireless coverage of the United States and Canada to conventional handsets. When completed, the network will support communications in a variety of market segments, including public safety, homeland security, aviation, transportation and entertainment, by providing a platform for interoperable, user-friendly and feature-rich voice and high-speed data services.

Dec 08, 2008 -- VION PHARMACEUTICALS, INC. (OTCBB: VION | Quote | Chart | News | PowerRating) today announced that additional survival data on its anticancer agent Onrigin(TM) (laromustine) injection was presented by the Company in a poster at the 50th American Society of Hematology Annual Meeting.

The poster presented survival data for a combined group of 140 de novo poor-risk acute myelogenous leukemia (AML) patients age 60 or older who achieved either a complete response (CR) or a complete response with incomplete platelet recovery (CRp) to Onrigin(TM).

The Kaplan-Meier estimate of median overall survival for patients who responded to Onrigin(TM) was 8.4 months. Median overall survival for all patients was 3.3 months. Six, twelve and twenty-four month survival rate estimates were as follows:

Responders (N=52) All Patients (N=140) 6 months 57% 34%

12 months 39% 21%

24 months 20% 10%

Ann Cahill, Vice President, Clinical Development, commented, "In the treatment of AML, achievement of a complete response is the critical first step in the continuum of care." She added, "We believe that Onrigin(TM), if approved, will represent an important new treatment option for these poor-risk AML patients."

The overall response rate (CR plus CRp) in the combined group was 37%, with 40 patients (29%) achieving a CR and 12 patients (9%) achieving a CRp. The induction death rate (death within thirty days from all causes) was 14%. The most common Serious Adverse Events (SAEs) for the combined patient group were in the following system organ classes: infections and infestations (34%); blood and lymphatic disorders (24%) and respiratory, thoracic and mediastinal disorders (22%).

The analysis included patients from two clinical trials conducted by the Company in elderly AML patients in the past four years: (i) 85 de novo poor-risk patients were from a pivotal Phase II study, CLI-043, and (ii) a subset of 55 de novo poor-risk patients who reasonably met the eligibility criteria for CLI-043 were retrospectively identified from an additional Phase II study, CLI-033. In both studies, all patients received 600 mg/m2 of Onrigin(TM) in a single induction infusion of 30-60 minutes. Sixteen percent of the patients from both studies received a second induction dose of 600 mg/m2 of Onrigin(TM). Twenty-four percent of the combined patients received consolidation treatment upon achieving a response. Patients in CLI-043 received consolidation with 400 mg/m2 of cytarabine per day for five days and patients in CLI-033 received consolidation with 400 mg/m2 of Onrigin(TM).

About Vion

Vion Pharmaceuticals, Inc. is committed to extending the lives and improving the quality of life of cancer patients worldwide by developing and commercializing innovative cancer therapeutics. Vion has two agents in clinical trials. Onrigin(TM) (laromustine) injection, formerly known as Cloretazine(R) (VNP40101M), a unique alkylating agent, is being evaluated in a Phase II pivotal trial as a single agent in elderly patients with previously untreated de novo poor-risk acute myelogenous leukemia. Clinical trials of Onrigin(TM) with cytarabine in elderly patients with acute myelogenous leukemia, with standard remission-induction therapy in patients with AML and myelodysplatic syndromes (MDS), with temozolomide in brain tumors, and with stem cell transplantation in advanced hematologic malignancies, are also being conducted. Triapine(R), a potent inhibitor of a key step in DNA synthesis, is being evaluated in clinical trials sponsored by the National Cancer Institute.

About Standoutstocks.com

Standoutstocks.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies. Standoutstocks.com email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Standout StocksReport home page at www.Standoutstocks.com and select the "join now" button.

Join us at www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market.

Disclaimer: Verify all claims and do your own due diligence. Standoutstocks.com profiles are not a solicitation or recommendation to buy, sell or hold securities. Standoutstocks.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Standoutstocks.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Standoutstocks.com is owned and operated by Standoutstocks.com. Neither Standoutstocks.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Standoutstocks.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Standoutstocks.com statements and opinions and such statements and opinions cannot be considered independent. Standoutstocks.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Standoutstocks.com services are often paid for using free-trading shares. Standoutstocks.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

Visit us for a full Disclaimer at: www.standoutstocks.com/disclaimer.aspx

CONTACT: Standoutstocks.com e-mail: info@standoutstocks.com WWW: http://www.standoutstocks.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index